BiomX Inc (PHGE) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]
BiomX Inc. COmmon Stock (PHGE)
Company Research
Source: Yahoo! Finance
For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points BiomX Inc ( PHGE ) achieved a significant milestone by dosing the first patient in their phase 2B trial for BX004, targeting cystic fibrosis patients with pseudomonas infections. The FDA provided constructive feedback on BX004, recognizing the unmet need for treatments targeting chronic pseudomonas infections in cystic fibrosis patients. European trials for BX004 continue uninterrupted, as the nebulizer components are CE marked in Europe. Positive FDA feedback was received for BX011, targeting Staphylococcus aureus infection in diabetic foot infections, supporting the development strategy. BiomX Inc ( PHGE ) has a clear regulatory pathway for BX011, with no additional non-clinical studies required, aligning with FDA guidance for diabetic foot infection product development. Negative Points The FDA placed a clinical hold on US trial sites for BX004 due to
Show less
Read more
Impact Snapshot
Event Time:
PHGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHGE alerts
High impacting BiomX Inc. COmmon Stock news events
Weekly update
A roundup of the hottest topics
PHGE
News
- BiomX Provides Update on BX004 Phase 2b Trial in Cystic FibrosisGlobeNewswire
- BiomX Inc. Announces 1-for-19 Reverse Stock SplitGlobeNewswire
- BiomX outlines imminent FDA feedback and targets BX004 Phase IIb data in Q1 2026 while advancing BX011 for diabetic foot infections [Seeking Alpha]Seeking Alpha
- BiomX Inc. (PHGE) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates [Yahoo! Finance]Yahoo! Finance
PHGE
Earnings
- 11/12/25 - Beat
PHGE
Sec Filings
- 11/25/25 - Form 8-K
- 11/17/25 - Form 8-K
- 11/12/25 - Form 10-Q
- PHGE's page on the SEC website